Exclusive

Publication

Byline

Sri Lanka's Sonal Dinusha wins ICC Player of the Month honours for August 2026

Dubai, Sept. 17 -- Sri Lanka's rising batting star Sonal Dinusha, who troubled Team India during the recently concluded home Test series, has won the ICC Men's Player of the Month honours for August 2... Read More


The British School in Tokyo welcomes Delhi Capitals to inspire Japan's next generation

Tokyo, Sept. 17 -- As cricket returns to the Asian Games at Aichi-Nagoya 2026, the Indian women's team is set to take on hosts Japan in the quarter-finals of the competition on Friday, September 18. T... Read More


Sarah Jane Nader Eliminated From DWTS: Her Dating History, Pete Davidson Rumours And Sexuality Explained

India, Sept. 17 -- Sarah Jane Nader's Dancing With The Stars journey has come to an early end. The Love Thy Nader star and her professional partner Hailey Bills were eliminated during Night 2 of the S... Read More


Home First Finance Company India allots 3,681 equity shares under ESOP

Mumbai, Sept. 17 -- Home First Finance Company India has allotted 3,681 equity shares of Rs 2 each pursuant to exercise of Employee Stock Options under the ESOP schemes of the company. The paid-up sh... Read More


Singapore Clinical Trial: The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'The use of Landiolol in mitral valve sUrgery: a raNdomized, controlled, double-blind triAl. (LUNA... Read More


Singapore Clinical Trial: A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD0120, an Autologous Dual Targeting Chimeric Antigen Receptor T-cell (CAR-T) Therapy Directed Against BCMA and CD19, versus Autologous Stem Cell Transplant (ASCT) in Participants with Newly Diagnosed Multiple Myeloma who are Transplant Eligible (TE NDMM) (DURGA-6)

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase III, Open-label, Multicentre, Randomised Study Comparing Consolidation Treatment with AZD... Read More


Singapore Clinical Trial: A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Phase 1/1b Study of IAM1363 in Participants with Advanced Cancers Harboring HER2 Alterations'. ... Read More


Singapore Clinical Trial: A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or without Bevacizumab in Comparison to Active Observation with or without Bevacizumab as Maintenance Treatment in Participants with Newly Diagnosed FIGO Stage III/IV Non-Homologous Recombination Deficient Ovarian Cancer

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Open-label, Multicenter, Phase 3 Study to Investigate Mocertatug Rezetecan with or ... Read More


Singapore Clinical Trial: An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-08634404 Monotherapy or in Combination in Adult Participants with Early-Stage Resectable or Locally Advanced Unresectable Non-Small Cell Lung Cancer

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'An Interventional, Open-Label, Phase 2 Study to Investigate the Safety and Efficacy of PF-0863440... Read More


Singapore Clinical Trial: A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of MLC901 (NeuroAiD™II) in subjects with mild to moderate Alzheimer’s Disease (AD).

Singapore, Sept. 17 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the e... Read More